Viewing Study NCT04985851


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2025-12-25 @ 9:41 PM
Study NCT ID: NCT04985851
Status: UNKNOWN
Last Update Posted: 2023-12-01
First Post: 2021-06-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
Sponsor: Shanghai Chest Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module